Unique ID issued by UMIN | UMIN000053464 |
---|---|
Receipt number | R000060966 |
Scientific Title | Randomised, parallel-group study to compare the efficacy of jigger lotion versus potassium permanganate for the treatment of tungiasis in children in Vihiga County, Kenya |
Date of disclosure of the study information | 2024/04/01 |
Last modified on | 2024/07/29 10:26:15 |
Comparative study on jigger lotion versus potassium permanganate for the treatment of tungiasis in children in Vihiga County, Kenya
Comparison of jigger lotion versus potassium permanganate for tungiasis in Kenya
Randomised, parallel-group study to compare the efficacy of jigger lotion versus potassium permanganate for the treatment of tungiasis in children in Vihiga County, Kenya
Randomised, clinical study to compare jigger lotion versus potassium permanganate for tungiasis in children in Kenya
Africa |
Tungiasis
Dermatology |
Others
NO
To determine if jigger lotion is superior to KMnO4 solution for topical treatments for tungiasis in school-age children in Vihiga, Kenya
To assess the safety of jigger lotion and KMnO4 solution in children with tungiasis
Safety,Efficacy
Confirmatory
Phase III
Treatment-induced change (improvement or deterioration) in the skin condition affected by tungiasis within 2 weeks
Development of adverse events/effects and symptomatic improvements within 2 weeks
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Device,equipment |
Jigger lotion one or two times
0.05% potassium permanganate (KMnO4) solution, only once at the beginning
3 | years-old | <= |
Not applicable |
Male and Female
Patients aged three or older age with an established diagnosis of tungiasis with stage II or IIIa based on rapid assessment by Fortaleza classification, which describes flea viability signs such as pulsation of the abdomen, expulsion of eggs, and excretion of a faecal thread.
or more fleas, and any disability preventing active cooperation in the study and those who have received treatment four weeks before the intervention and allergic to any of the treatments studied will be excluded. The severe cases will be referred to the Subcounty or County hospital for further clinical treatment.
100
1st name | Yasuhiko |
Middle name | |
Last name | Kamiya |
Nagasaki University
School of Tropical Medicine and Global Health
8528523
1-12-4 Sakamoto, Nagasaki-city, Nagasaki
+81958197891
ykami@nagasaki-u.ac.jp
1st name | Yasuhiko |
Middle name | |
Last name | Kamiya |
Nagasaki University
School of Tropical Medicine
8528523
1-12-4 Sakamoto, Nagasaki-city, Nagasaki
+81958197891
ykami@nagasaki-u.ac.jp
Nagasaki University
Yasuhiko Kamiya
Other
Profit organization
Japan
Nagasaki University
1-12-4 Sakamoto, Nagasaki-city, Nagasaki
0958197891
ykami@nagasaki-u.ac.jp
NO
2024 | Year | 04 | Month | 01 | Day |
Unpublished
Main results already published
2024 | Year | 01 | Month | 25 | Day |
2024 | Year | 03 | Month | 07 | Day |
2024 | Year | 03 | Month | 04 | Day |
2024 | Year | 04 | Month | 12 | Day |
2024 | Year | 04 | Month | 13 | Day |
2024 | Year | 04 | Month | 23 | Day |
2024 | Year | 06 | Month | 10 | Day |
2024 | Year | 01 | Month | 28 | Day |
2024 | Year | 07 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060966